Hope for Huntington’s disease patients

Scientists at Israel’s Weizmann Institute have identified two small molecules capable, in the laboratory, of penetrating the blood-brain barrier and reducing the levels of a defective protein that causes Huntington’s disease.




This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *